HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future

• Main Authors: Luying Xu (Author), Yuxin Xie (Author), Qiheng Gou (Author), Rui Cai (Author), Rong Bao (Author), Yucheng Huang (Author), Ruisi Tang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Breast cancer (BC) has the second highest incidence among cancers and is the leading cause of death among women worldwide. The human epidermal growth factor receptor 2 (HER2) is overexpressed in approximately 20%-30% of BC patients. The development of HER2-targeted drugs, including monoclonal antibo...